Skip to main content
. 2021 Oct 20;8(2):e001857. doi: 10.1136/openhrt-2021-001857

Table 1.

Patient characteristics

All (n=1045) Men (n=794) Women (n=251) P value
Age, years 56.4±13.5 55.1±13.9 60.3±11.5 <0.001
BSA, m2 1.99±0.22 2.05±0.19 1.81±0.20 <0.001
Hypertension, n (%) 438 (41.9) 330 (41.6) 108 (43.0) 0.682
Diabetes, n (%; n=583) 52 (8.9) 36 (8.5) 16 (10.1) 0.553
Dyslipidaemia, n (%) 133 (12.7) 100 (12.6) 33 (13.1) 0.819
CABG, n (%) 51 (4.9) 47 (5.9) 4 (1.6) 0.006
Phenotype
 RL, n (%) 769 (73.6) 590 (74.3) 179 (71.3) 0.634
 RN, n (%) 169 (16.2) 122 (15.4) 47 (18.7)
 LN, n (%) 11 (1.1) 9 (1.1) 2 (0.8)
 2-sinus, n (%) 96 (9.2) 73 (9.2) 23 (9.2)
Valve disease
 Aortic valve stenosis, n (%) 696 (66.6) 491 (61.8) 205 (81.7) <0.001
 Aortic valve insufficiency, n (%) 276 (26.4) 252 (31.7) 24 (9.6) <0.001
 Dilatation only, n (%) 73 (7.0) 51 (6.4) 22 (8.8) 0.205
Aortic dimensions*
 Annulus, cm 2.6±0.4 (n=768) 2.7±0.4 (n=574) 2.3±0.3 (n=194) <0.001
 Sinus of Valsalva, cm 3.7±0.6 (n=887) 3.8±0.6 (n=666) 3.3±0.6 (n=221) <0.001
 Sinotubular junction, cm 3.1±0.6 (n=660) 3.3±0.6 (n=492) 2.8±0.6 (n=168) <0.001
 Ascending aorta, cm 4.2±0.8 (n=919) 4.2±0.8 (n=694) 4.0±0.8 (n=225) 0.581
Aortopathy
 Any dilatation, n (%; n=1003) 351 (35.0) 284 (37.3) 67 (27.8) 0.007
 Ascending phenotype, n (%) 271 (27.0) 208 (27.3) 63 (26.1) 0.725
 Root phenotype, n (%) 19 (1.9) 18 (2.4) 1 (0.4) 0.058
 Root extended, n (%) 61 (6.1) 58 (7.6) 3 (1.2) <0.001

*P values adjusted for BSA and age.

BSA, body surface area; CABG, coronary artery bypass grafting; LN, left-non-coronary fusion;; RL, right–left fusion; RN, right-non-coronary fusion.